Biontech SE
BNTX98.080USD
0.000
종가 09/26, 16:00（ET）시세는 15분 지연됩니다
23.58B시가총액
손실P/E TTM
자세한 내용은 회사
회사 정보
종목 코드 BNTX
회사 이름Biontech SE
상장일Oct 10, 2019
CEOProf. Ugur Sahin, M.D.
직원 수6772
유형Depository Receipt
회계 연도 종료Oct 10
주소An der Goldgrube 12
도시MAINZ
증권 거래소NASDAQ Global Select Consolidated
국가Germany
우편 번호55131
전화4949613190840
웹사이트https://www.biontech.com/
종목 코드 BNTX
상장일Oct 10, 2019
CEOProf. Ugur Sahin, M.D.
회사 임원
이름
이름/직위
직위
주식 보유
변동
Dr. Sierk Poetting, Ph.D.
Dr. Sierk Poetting, Ph.D.
Chief Operating Officer, Member of the Management Board
Chief Operating Officer, Member of the Management Board
767.54K
+1.69%
Mr. Ryan Richardson
Mr. Ryan Richardson
Chief Strategy Officer, Member of the Management Board
Chief Strategy Officer, Member of the Management Board
26.55K
+80.66%
Dr. Ulrich Wandschneider, Ph.D.
Dr. Ulrich Wandschneider, Ph.D.
Independent Deputy Chairman of the Supervisory Board
Independent Deputy Chairman of the Supervisory Board
1.48K
--
Mr. James Ryan
Mr. James Ryan
Member of the Management Board, Chief Legal Officer
Member of the Management Board, Chief Legal Officer
790.00
--
Prof. Rudolf Staudigl, Ph.D.
Prof. Rudolf Staudigl, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
400.00
--
Prof. Anja Morawietz, Ph.D.
Prof. Anja Morawietz, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
240.00
--
Mr. Ramon Zapata Gomez
Mr. Ramon Zapata Gomez
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Helmut Jeggle
Mr. Helmut Jeggle
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
--
--
Dr. Oezlem Tuereci, M.D.
Dr. Oezlem Tuereci, M.D.
Chief Medical Office, Member of the Management Board
Chief Medical Office, Member of the Management Board
--
--
Ms. Baroness Nicola Blackwood
Ms. Baroness Nicola Blackwood
Member of the Supervisory Board
Member of the Supervisory Board
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Sierk Poetting, Ph.D.
Dr. Sierk Poetting, Ph.D.
Chief Operating Officer, Member of the Management Board
Chief Operating Officer, Member of the Management Board
767.54K
+1.69%
Mr. Ryan Richardson
Mr. Ryan Richardson
Chief Strategy Officer, Member of the Management Board
Chief Strategy Officer, Member of the Management Board
26.55K
+80.66%
Dr. Ulrich Wandschneider, Ph.D.
Dr. Ulrich Wandschneider, Ph.D.
Independent Deputy Chairman of the Supervisory Board
Independent Deputy Chairman of the Supervisory Board
1.48K
--
Mr. James Ryan
Mr. James Ryan
Member of the Management Board, Chief Legal Officer
Member of the Management Board, Chief Legal Officer
790.00
--
Prof. Rudolf Staudigl, Ph.D.
Prof. Rudolf Staudigl, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
400.00
--
Prof. Anja Morawietz, Ph.D.
Prof. Anja Morawietz, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
240.00
--
수익 분석
통화: USD마지막 업데이트: Wed, Mar 12
통화: USD마지막 업데이트: Wed, Mar 12
FY2019
FY2018
FY2017
사업별USD
이름
수익
비율
Collaboration Revenue
84.43M
77.75%
Revenues from Other Sales Transactions
24.16M
22.25%
데이터 없음
사업별
지역별
사업별USD
이름
수익
비율
Collaboration Revenue
84.43M
77.75%
Revenues from Other Sales Transactions
24.16M
22.25%
주식 보유 통계
마지막 업데이트: Sun, Aug 17
마지막 업데이트: Sun, Aug 17
주주
주주 유형
주주
주주
비율
AT Impf GmbH
42.37%
Medine GmbH
16.69%
Baillie Gifford & Co.
3.34%
Fidelity Management & Research Company LLC
2.90%
Flossbach von Storch AG
1.76%
기타
32.93%
주주
주주
비율
AT Impf GmbH
42.37%
Medine GmbH
16.69%
Baillie Gifford & Co.
3.34%
Fidelity Management & Research Company LLC
2.90%
Flossbach von Storch AG
1.76%
기타
32.93%
주주 유형
주주
비율
Corporation
60.58%
Investment Advisor
16.91%
Investment Advisor/Hedge Fund
3.59%
Individual Investor
2.11%
Research Firm
1.00%
Hedge Fund
0.83%
Sovereign Wealth Fund
0.63%
Bank and Trust
0.22%
Pension Fund
0.19%
기타
13.94%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
815
205.26M
85.38%
-4.32M
2025Q1
851
205.71M
85.57%
-4.55M
2024Q4
869
205.33M
85.56%
+3.19M
2024Q3
843
197.46M
82.52%
-2.61M
2024Q2
819
194.42M
81.78%
-7.50M
2024Q1
835
193.57M
81.42%
-10.02M
2023Q4
897
193.24M
81.29%
-7.90M
2023Q3
920
192.71M
79.62%
-7.47M
2023Q2
940
195.49M
80.61%
-8.54M
2023Q1
953
197.88M
81.52%
-6.52M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
AT Impf GmbH
101.85M
42.37%
-636.54K
-0.62%
Dec 31, 2024
Medine GmbH
40.13M
16.69%
-304.48K
-0.75%
Mar 31, 2025
Baillie Gifford & Co.
8.16M
3.39%
-60.90K
-0.74%
Mar 31, 2025
Fidelity Management & Research Company LLC
5.95M
2.48%
-495.85K
-7.69%
Mar 31, 2025
Flossbach von Storch AG
4.26M
1.77%
-147.21K
-3.34%
Mar 31, 2025
PRIMECAP Management Company
4.05M
1.68%
-249.39K
-5.81%
Mar 31, 2025
Pfizer Inc
3.66M
1.52%
--
--
Mar 31, 2025
Sahin (Ugur MD)
2.05M
0.85%
-724.50K
-26.11%
Mar 31, 2025
Temasek Holdings Pte. Ltd.
1.81M
0.75%
--
--
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Sep 6
마지막 업데이트: Sat, Sep 6
이름
비율
iShares Genomics Immunology and Healthcare ETF
3.71%
Global X Genomics & Biotechnology ETF
3.6%
Langar Global HealthTech ETF
3.46%
First Trust NYSE Arca Biotechnology Index Fund
2.97%
Franklin Genomic Advancements ETF
2.68%
VanEck Biotech ETF
2.65%
WisdomTree BioRevolution Fund
1.8%
Virtus LifeSci Biotech Products ETF
1.74%
iShares Biotechnology ETF
1.44%
ProShares Ultra Nasdaq Biotechnology
1.15%
더 보기
iShares Genomics Immunology and Healthcare ETF
비율3.71%
Global X Genomics & Biotechnology ETF
비율3.6%
Langar Global HealthTech ETF
비율3.46%
First Trust NYSE Arca Biotechnology Index Fund
비율2.97%
Franklin Genomic Advancements ETF
비율2.68%
VanEck Biotech ETF
비율2.65%
WisdomTree BioRevolution Fund
비율1.8%
Virtus LifeSci Biotech Products ETF
비율1.74%
iShares Biotechnology ETF
비율1.44%
ProShares Ultra Nasdaq Biotechnology
비율1.15%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
